1,796 material Form 8-K filings that 1,448 companies we cover made with the SEC in May 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Gap Inc. reported first quarter fiscal 2026 net sales of $3.5 billion, up 1%, and GAAP diluted EPS of $0.90 versus $0.51 a year earlier. Results include a $313 million net gain from a credit card interchange fee litigation settlement and a $50 million charitable contribution; excluding these items, adjusted diluted EPS was $0.38. The company raised its adjusted fiscal 2026 EPS outlook to $2.30 to $2.40 from $2.20 to $2.35, but lowered its net sales growth outlook to 1% to 2% from 2% to 3%.
Net sales of $3.5 billion were up 1%; comparable sales were up 2%, the ninth consecutive quarter of positive comparable sales.
Gross margin was 40.5%, down 130 basis points; merchandise margin was down 100 basis points, including an estimated net tariff impact of about 200 basis points.
Returned $464 million to shareholders in the quarter, including a $200 million accelerated share repurchase and $201 million of open-market repurchases.
Adjusted FY2026 diluted EPS outlook is $2.30 to $2.40, up from $2.20 to $2.35; net sales outlook is 1% to 2%, down from 2% to 3%.
Hormel reported fiscal second-quarter 2026 net sales of $2.97 billion, up 2.5% from a year earlier, but GAAP operating income fell to $217 million from $248 million and GAAP diluted EPS was $0.29 versus $0.33. The company lowered its fiscal 2026 GAAP diluted EPS guidance to $1.28 to $1.37 from $1.37 to $1.46, reflecting the $61 million loss on the whole-bird turkey sale, while reaffirming adjusted diluted EPS guidance of $1.43 to $1.51.
Q2 net sales $2.97 billion, up 2.5%; organic net sales up 3%
Q2 GAAP diluted EPS $0.29 vs $0.33 a year earlier; adjusted diluted EPS $0.40 vs $0.35
Fiscal 2026 GAAP diluted EPS guidance cut to $1.28 to $1.37 from $1.37 to $1.46; adjusted EPS guidance reaffirmed at $1.43 to $1.51
Loss on the whole-bird turkey business sale, including transaction costs, was $61 million in the quarter
Synopsys reported second-quarter fiscal 2026 revenue of $2.276 billion, up from $1.604 billion a year earlier, and raised its full-year revenue and non-GAAP EPS targets. GAAP net income fell to $17.1 million, or $0.09 per diluted share, from $349.2 million a year earlier, and included $115.9 million in restructuring charges.
Q2 revenue $2.276 billion vs $1.604 billion a year earlier; non-GAAP EPS $3.35 vs $3.67.
GAAP net income $17.1 million ($0.09 per diluted share) vs $349.2 million ($2.24) a year earlier.
Full-year fiscal 2026 revenue midpoint raised to $9.665 billion from $9.610 billion; non-GAAP EPS midpoint raised to $14.76.
Marvell reported first-quarter fiscal 2027 revenue of $2.418 billion, a record and up 28% from a year earlier, and guided second-quarter revenue to $2.7 billion at the mid-point. GAAP net income fell to $34.5 million, or $0.04 per diluted share, from $177.9 million a year earlier, mainly because of a $250.7 million special item, while non-GAAP diluted EPS rose to $0.80 from $0.62. The company said it is raising its revenue outlook for both fiscal 2027 and fiscal 2028.
Q1 fiscal 2027 net revenue was $2.418 billion, up 28% year over year and $18.0 million above the mid-point of guidance given March 5, 2026
GAAP diluted EPS was $0.04 versus $0.20 a year earlier; non-GAAP diluted EPS was $0.80 versus $0.62
Q2 fiscal 2027 revenue guidance is $2.700 billion, plus or minus 5%, with non-GAAP diluted EPS guided to $0.93, plus or minus $0.05
Bath & Body Works reported first quarter 2026 net sales of $1,378 million, down 3% from a year earlier, and reaffirmed its full-year 2026 guidance. Reported earnings per diluted share rose to $0.90 from $0.49, but that figure includes an $88 million pre-tax litigation settlement gain and a $62 million tax benefit, while adjusted EPS was $0.32 versus $0.49 last year. Chief Financial Officer Eva Boratto will step down June 12, and Tom Javitch will serve as interim CFO while the company searches for a successor.
Q1 2026 net sales were $1,378 million, down 3% from $1,424 million in Q1 2025.
Reported diluted EPS was $0.90 versus $0.49; adjusted diluted EPS was $0.32 versus $0.49.
Full-year 2026 guidance reaffirmed: net sales down 4.5% to 2.5%, adjusted diluted EPS $2.40 to $2.65.
Second-quarter 2026 diluted EPS is expected at $0.20 to $0.25; CFO Eva Boratto steps down June 12 and Tom Javitch becomes interim CFO.
DICK'S reported first-quarter net sales of $5.16 billion, up 62.7% from a year earlier, with the Foot Locker acquisition included for the full quarter. GAAP diluted earnings per share rose to $3.54 from $3.24, but non-GAAP earnings per share fell to $2.90 from $3.37, and the company lowered its full-year GAAP earnings per share guidance while keeping its non-GAAP range unchanged.
First-quarter net sales $5.16 billion vs. $3.18 billion a year earlier; Foot Locker acquisition closed September 8, 2025
Diluted EPS $3.54 GAAP vs. $3.24 prior year; non-GAAP $2.90 vs. $3.37
Full-year 2026 GAAP diluted EPS guidance cut to $13.27 to $14.27 from $13.70 to $14.70; non-GAAP range of $13.50 to $14.50 unchanged
DICK'S Business comparable sales outlook low end raised to 2.5% from 2.0%; quarterly dividend of $1.25 per share payable June 26, 2026
Transcat reported fiscal fourth quarter 2026 results for the period ended March 28, 2026, with revenue up 15.8% to $89.3 million while net income fell 56.4% to $1.9 million and diluted EPS fell to $0.21 from $0.48. For the full fiscal year, revenue rose 19.2% to $331.9 million, but net income fell 63.0% to $5.4 million, and the company expects high single-digit service organic revenue growth in fiscal 2027.
Q4 fiscal 2026 revenue was $89.3 million, up 15.8%, with service revenue up 18.4% to $61.6 million and distribution revenue up 10.5% to $27.8 million.
Q4 operating income fell 37.6% to $4.3 million, and net income fell to $1.9 million from $4.5 million a year earlier.
Adjusted EBITDA rose 16.0% to $14.8 million in Q4, while total debt was $99.9 million as of March 28, 2026, up from $32.7 million a year earlier.
Management guided to high single-digit service organic revenue growth for fiscal 2027, assuming a stable economic environment.
Booz Allen reported fiscal 2026 results for the year ended March 31, 2026, with revenue down 6.4% to $11.2 billion while adjusted diluted EPS rose 2.5% to $6.51. Its fiscal 2027 guidance projects adjusted diluted EPS of $6.00 to $6.35, below the fiscal 2026 figure, and revenue of $11.2 billion to $11.7 billion.
Q4 fiscal 2026 revenue was $2.8 billion, down 6.4% year over year, while adjusted diluted EPS was $1.78, up 10.6%.
Fiscal 2026 GAAP diluted EPS was $6.90, down 4.8%, and net income was $851 million, down 9.0%.
Fiscal 2027 guidance: revenue $11.2 billion to $11.7 billion, adjusted diluted EPS $6.00 to $6.35, and free cash flow $825 million to $925 million.
The board declared a regular quarterly dividend of $0.59 per share, payable June 26, 2026, to holders of record on June 10, 2026.
Flowers Foods reported first-quarter 2026 results for the 16 weeks ended April 25, 2026. Net sales rose 1.1% to $1.572 billion, but net income fell 20.6% to $42.1 million, and the company reset its annual dividend rate to $0.50 per share while reaffirming its 2026 adjusted EPS outlook of $0.80 to $0.90.
Net sales rose 1.1% to $1.572 billion, helped by the Simple Mills acquisition and pricing/mix, while volume fell 3.3%.
Net income fell 20.6% to $42.1 million; adjusted diluted EPS fell to $0.29 from $0.35.
Quarterly dividend of $0.1250 per share, payable June 26, 2026, to shareholders of record June 12, 2026.
Fiscal 2026 guidance was reaffirmed, including adjusted diluted EPS of approximately $0.80 to $0.90.
Intuit reported fiscal third-quarter 2026 revenue of $8.6 billion, up 10%, and GAAP diluted earnings per share of $11.09, up 11%, and raised its full-year fiscal 2026 revenue guidance. The company also announced a plan to cut its full-time workforce by approximately 17% and estimated $300 million to $340 million in charges, mainly in the fourth fiscal quarter, which will weigh on reported GAAP results.
Q3 revenue of $8.6 billion, up 10%; non-GAAP diluted EPS of $12.80, up 10%
Full-year fiscal 2026 revenue guidance raised to $21.341 billion to $21.374 billion
Workforce reduction of approximately 17%, with charges of $300 million to $340 million, primarily in the quarter ending July 31, 2026
Quarterly dividend of $1.20 per share, payable July 17, 2026, to holders of record on July 9, 2026
Roivant reported fourth-quarter net income attributable to the company of $303 million, compared with a loss of $206 million a year earlier, mainly due to a $770.2 million gain on the Moderna litigation settlement. Q4 revenue fell to $2.5 million from $7.6 million, and the full-year net loss attributable to the company widened to $299.8 million from $172.0 million, so the one-time gain does not reflect a steady operating improvement.
Q4 ended March 31, 2026: net income attributable to Roivant $303.0 million, or $0.28 diluted per share, versus a loss of $206.5 million ($0.29 per share) a year earlier
Gain on litigation settlement of $770.2 million; Q4 revenue $2.5 million versus $7.6 million
Full year: loss from continuing operations $397.9 million versus $729.8 million; net loss attributable to Roivant $299.8 million versus $172.0 million
Cash, cash equivalents and marketable securities of $4.3 billion as of March 31, 2026; Moderna to pay $950 million in July 2026 with an additional $1.3 billion contingent on an appeal
VF Corp reported fourth-quarter revenue of $2.17 billion, up 1% from a year earlier, and an operating profit of $62 million versus a $73 million loss in the prior-year quarter. The quarter still produced a net loss of $119 million, or $0.30 per diluted share, mainly due to non-cash pension settlement charges tied to terminating its U.S. qualified plan. The company reinstated annual guidance for fiscal 2027 calling for revenue growth of 1% to 2% in constant currency, which signals management expects continued expansion.
Q4 FY2026 revenue was $2,166.0 million, up 1% from $2,143.8 million; excluding Dickies, revenue rose 8%
Q4 net loss was $119.3 million, or $0.30 per diluted share, versus a $0.39 loss a year earlier; pension settlement charges of about $158 million were excluded from adjusted results
Full-year FY2026 diluted EPS from continuing operations was $0.64 versus $0.18, and revenue was $9,605.2 million, up 1%
FY2027 guidance: revenue up 1% to 2% in constant currency, adjusted operating margin of about 8%, and free cash flow flat to up from $405 million; quarterly dividend of $0.09 payable June 18, 2026
Toll Brothers reported second-quarter fiscal 2026 results for the three months ended April 30, 2026, with net income of $260.6 million ($2.72 per diluted share), down from $352.4 million ($3.50) a year earlier. Home sales revenues fell to $2.51 billion from $2.71 billion as deliveries declined to 2,491 homes from 2,899. Management said it is raising full-year guidance across its key home building metrics based on year-to-date performance.
Net income $260.6 million, or $2.72 per diluted share, versus $352.4 million, or $3.50, a year earlier
Home sales revenues $2.51 billion on 2,491 deliveries, versus $2.71 billion on 2,899 deliveries
Adjusted home sales gross margin 26.2% versus 27.5%; SG&A at 10.3% of home sales revenues versus 9.5%
Full-year FY 2026 guidance includes 10,400 to 10,700 deliveries and an adjusted home sales gross margin of 26.10%
CAVA reported fiscal first quarter 2026 results for the 16-week period ended April 19, 2026. Revenue rose 32.2% to $434.4 million and same restaurant sales rose 9.7%, but net income fell to $23.6 million from $25.7 million, and diluted EPS was $0.20 versus $0.22. The company raised its fiscal 2026 guidance for same restaurant sales and Adjusted EBITDA.
Revenue of $434.4 million, up 32.2% from $328.5 million a year earlier; same restaurant sales rose 9.7%, including 6.8% guest traffic growth.
Net income of $23.6 million versus $25.7 million; the filing cites a lower tax benefit from equity-based compensation and higher depreciation and amortization.
Adjusted EBITDA of $61.7 million, up 37.6%; the company opened 20 net new restaurants, bringing the total to 459.
Fiscal 2026 guidance raised: same restaurant sales to 4.5% to 6.5% (from 3.0% to 5.0%) and Adjusted EBITDA to $181.0 million to $191.0 million (from $176.0 million to $184.0 million).
Data Storage Corp reported first-quarter 2026 sales of $346,707, up from $312,744 a year earlier, but posted a net loss attributable to common stockholders of $631,272, compared with net income of $24,078 in the prior-year quarter. The company also announced Sovereign AI Solutions, a wholly owned subsidiary for AI continuity infrastructure, and its cash flow statement shows $29.5 million spent on share repurchases in connection with a tender offer, with marketable securities falling to $9.6 million from $39.0 million at year-end 2025.
Sales were $346,707 versus $312,744 a year earlier; gross profit rose to $186,019 from $140,777.
Selling, general and administrative expense rose to $1,472,113 from $856,915, and the operating loss widened to $1,286,094 from $716,138.
Basic and diluted loss per share attributable to common stockholders was $(0.20), versus $0.00 a year earlier.
Share repurchases in connection with a tender offer totaled $29,528,957; Nexxis sales rose 10.9% and gross margin was 53.7% versus 45.0%.
Infleqtion reported first-quarter 2026 revenue of $9.5 million, up 14% from a year earlier, and raised its 2026 revenue guidance to at least $40 million. The net loss widened to $30.3 million from $6.0 million, though the per-share loss narrowed to $0.26 from $0.41 on a much larger share count after the go-public transaction.
Q1 2026 revenue of $9.5 million, up 14% year over year
GAAP net loss of $30.3 million, or $0.26 per share, versus a net loss of $6.0 million, or $0.41 per share, in Q1 2025
Go-public transaction expenses of $11.5 million and stock-based compensation of $8.3 million were included in GAAP results
Cash, cash equivalents and available-for-sale securities totaled $569 million as of March 31, 2026
Pixelworks reported first-quarter 2026 results, with net income of $80.6 million driven by a $85.2 million gain from discontinued operations tied to the January sale of its Shanghai subsidiary. Revenue was about $446,000, up from zero a year earlier, but the loss from continuing operations widened to $4.6 million from $2.8 million, including $2.0 million of restructuring costs. Shareholders also get a $5 million buyback authorization and cash of about $58 million with no debt.
Net income attributable to Pixelworks was $80.6 million, or $12.69 per basic share, versus a net loss of $7.8 million a year earlier.
Revenue was $446,000 versus zero in Q1 2025; loss from operations was $4.9 million versus $3.1 million.
Restructuring expense was $2.0 million; cash and cash equivalents were $57.8 million at March 31, 2026, with no debt.
The Board authorized a $5 million stock repurchase program on March 30, 2026, beginning May 15, 2026; the company targets cash operating expenses of about $2 million per quarter from Q2.
York Space Systems reported first-quarter 2026 revenue of $116.3 million, up 9% from a year earlier, but its net loss widened to $114.8 million from $11.7 million, driven largely by an $84.7 million stock compensation expense. The company reaffirmed its full-year 2026 revenue guidance of $545 million to $595 million, which matters to shareholders because revenue grew while profitability weakened sharply.
Revenue rose to $116.3 million from $106.3 million, while gross margin fell to 19% from 23%.
Net loss was $114.8 million versus $11.7 million a year earlier; adjusted EBITDA was a loss of $3.6 million versus a $5.5 million profit.
Full-year 2026 revenue guidance of $545 million to $595 million was reaffirmed as of May 14, 2026.
Backlog rose to $642 million from $543 million at December 31, 2025, and cash was $656 million at March 31, 2026.
Figma reported first-quarter 2026 results on May 14, 2026, with revenue of $333.4 million, up 46% year over year and above its prior first-quarter guidance range. The company raised its full-year 2026 revenue guidance by $55 million, but its GAAP net loss was $142.4 million, compared with net income of $44.9 million a year earlier, so shareholders face a mixed picture of stronger sales and outlook alongside a larger GAAP loss.
Q1 2026 revenue was $333.4 million, up 46% year over year, versus 40% growth in Q4 2025.
Full-year 2026 revenue guidance is $1.422 billion to $1.428 billion, a $55 million raise; non-GAAP operating income guidance is $125.0 million to $135.0 million.
Second-quarter 2026 revenue outlook is $348.0 million to $350.0 million.
GAAP net loss was $142.4 million, or $(0.27) per share, versus net income of $44.9 million in Q1 2025; non-GAAP net income was $56.5 million.
YETI reported first quarter 2026 sales up 8% to $380.4 million, while diluted EPS fell 35% to $0.13 from $0.20 and adjusted EPS fell 16% to $0.26, including a $0.09 unfavorable net impact from incremental tariffs. The company raised its 2026 adjusted EPS outlook to $2.83 to $2.89 and increased its share repurchase authorization to $500 million, which matters to shareholders because the earnings forecast rose and buyback capacity expanded even though profit declined in the quarter.
Q1 2026 net sales rose 8% to $380.4 million; wholesale sales rose 19% to $183.6 million, while direct-to-consumer sales were flat at $196.8 million
Diluted EPS fell 35% to $0.13 from $0.20; net income fell 41% to $9.9 million; operating income margin was 3.3%
2026 adjusted EPS outlook raised to $2.83 to $2.89, up from $2.77 to $2.83; sales growth outlook low end raised to 7% to 8%
Board increased share repurchase authorization to $500 million available as of May 14, 2026; outlook includes $100 million in expected 2026 repurchases
Marchex reported first-quarter 2026 revenue of $10.6 million, down from $11.4 million a year earlier, while its net loss narrowed to $1.7 million from $2.0 million. The company raised its second-quarter 2026 Adjusted EBITDA guidance to $1.6 million to $1.8 million, up from prior guidance of more than $1 million, and said the proposed Archenia acquisition is expected to close in July 2026 if stockholders approve it.
Q1 2026 revenue was $10.6 million versus $11.4 million in Q1 2025.
Net loss was $1.7 million, or $(0.04) per diluted share, versus $2.0 million, or $(0.05), a year earlier.
Q2 2026 Adjusted EBITDA is now expected to be $1.6 million to $1.8 million, up from prior guidance of more than $1 million.
Marchex signed a Stock Purchase Agreement on May 8, 2026 to acquire 100% of Archenia, Inc.; closing is expected in July 2026, subject to majority approval by disinterested stockholders.
Doximity reported fiscal fourth-quarter 2026 revenue of $145.4 million, up 5%, but GAAP net income fell to $19.1 million from $62.5 million and adjusted EBITDA declined 6%. The company also gave fiscal 2027 revenue guidance of $664 million to $676 million and named Matthew Sonefeldt as chief financial officer and Steven L. Zatz, M.D. as president, both effective May 13, 2026.
Q4 revenue $145.4 million vs. $138.3 million; net income $19.1 million vs. $62.5 million; diluted EPS $0.10 vs. $0.31
Q4 adjusted EBITDA $65.8 million vs. $69.7 million; full-year fiscal 2026 revenue $644.9 million, up 13%
Fiscal 2027 guidance: revenue $664 million to $676 million; adjusted EBITDA $323 million to $335 million; fiscal Q1 revenue $151 million to $152 million
Matthew Sonefeldt becomes principal financial officer June 8, 2026; Siddharth Sitaram serves as interim PFO through June 7, 2026
Grocery Outlet reported a first-quarter fiscal 2026 net loss of $180.3 million, or $(1.83) per diluted share, compared with a net loss of $23.3 million, or $(0.24), a year earlier. The loss reflects a $158.0 million non-cash goodwill impairment, while net sales rose 3.6% to $1.17 billion, and the company reaffirmed its fiscal 2026 guidance. For shareholders, sales growth was offset by a sharp decline in profit and a much larger per-share loss.
Net sales rose 3.6% to $1.17 billion, but comparable store sales declined 1.0%.
Net loss was $180.3 million, or $(1.83) per diluted share, versus $23.3 million, or $(0.24), a year earlier, including the $158.0 million goodwill impairment.
Adjusted EBITDA was $43.1 million, or 3.7% of net sales, compared with $51.9 million, or 4.6%, last year.
Fiscal 2026 guidance was reaffirmed, including adjusted EBITDA of $220 million to $235 million and diluted adjusted EPS of $0.45 to $0.55.
Nextpower reported fiscal fourth-quarter 2026 revenue of $881 million and GAAP diluted EPS of $0.97, both below the year-earlier quarter, while full-year fiscal 2026 revenue rose to $3.56 billion and GAAP diluted EPS reached $3.84. The company raised its fiscal 2027 revenue outlook to $3.8 billion to $4.1 billion from $3.6 billion to $3.8 billion, and it also announced a planned acquisition of power conversion product lines subject to Spanish government approval.
Q4 FY26 revenue $881 million vs. $924 million in Q4 FY25; GAAP diluted EPS $0.97 vs. $1.05
Full-year FY26 revenue $3.56 billion; GAAP diluted EPS $3.84 vs. $3.47 in FY25
FY27 outlook: revenue $3.8 billion to $4.1 billion; Adjusted EBITDA $825 million to $900 million
Robert Vinje appointed Chief Operating Officer effective June 15, 2026; Marco Miller moves to Chief Project Development Officer
Evolv Technology reported first-quarter 2026 revenue of $46.3 million, up 45% from a year earlier, and ending annual recurring revenue of $127.3 million, up 20%. The company raised its 2026 total revenue outlook to $175 million to $180 million, but its net loss widened to $5.0 million from $1.7 million, which shareholders should weigh against the higher sales and guidance.
Q1 2026 revenue was $46.3 million, up 45% from $32.0 million in Q1 2025.
Net loss was $5.0 million, or $(0.03) per share, versus $1.7 million, or $(0.01) per share, in Q1 2025.
2026 total revenue outlook raised to $175 million to $180 million from $172 million to $178 million issued March 10, 2026.
Cash, cash equivalents and marketable securities were $61.1 million as of March 31, 2026.
TriSalus Life Sciences reported first quarter 2026 revenue of $8.9 million, down 2.9% from a year earlier, and revised its 2026 revenue guidance to $54 million to $57 million. Net income was $1.5 million, or $0.03 per share, but that result reflected $11.3 million of non-cash derivative gains, while the operating loss widened, so shareholders face a mixed picture.
Q1 2026 revenue was $8.9 million, down 2.9% from $9.2 million in Q1 2025, which the company attributed mainly to its commercial expansion.
Operating loss widened to $8.4 million from $7.3 million, and adjusted EBITDA loss widened to $5.8 million from $5.5 million.
Net income attributable to common stockholders was $1.5 million, or $0.03 per share, versus a net loss of $11.1 million, or $(0.39) per share, a year earlier; the company cited $11.3 million of non-cash fair value gains on derivatives.
2026 revenue guidance was revised to $54 million to $57 million, citing lower Q1 revenue and delayed FDA clearance timing for TriNav Advance; cash totaled $56.6 million on March 31, 2026, after a $46.0 million gross equity raise.
Under Armour reported fourth-quarter and full-year fiscal 2026 results on May 12, 2026. Revenue fell 1% to $1.2 billion in the quarter and 4% to $5.0 billion for the year, and the company posted a full-year net loss of $496 million. It also raised the total cost of its fiscal 2025 restructuring plan to approximately $305 million and gave initial fiscal 2027 guidance that includes operating income of $96 million to $116 million.
Q4 fiscal 2026 revenue fell 1% to $1.2 billion; net loss was $43 million, or $0.10 per share, versus a $67 million loss ($0.16 per share) a year earlier.
Full-year net loss was $496 million ($1.16 per share), including a $247 million valuation allowance on U.S. federal deferred tax assets.
Total fiscal 2025 restructuring plan costs were raised to approximately $305 million from the previous $255 million, with completion expected by December 31, 2026.
Fiscal 2027 outlook: operating income of $96 million to $116 million and GAAP diluted loss per share of breakeven to $0.04.
Ralliant reported first-quarter 2026 revenue of $535 million, up 11% from a year earlier, and raised its full-year 2026 outlook. GAAP net earnings fell to $44 million, or $0.39 per diluted share, from $63.9 million, or $0.57, a year earlier, so shareholders see higher sales alongside lower reported profit. The company also raised its share repurchase authorization to $500 million.
Revenue of $535 million, up 11% year over year and up 9% organically; net earnings of $44 million, or $0.39 per diluted share, versus $0.57 a year earlier
Full-year 2026 guidance: revenue of $2.185 to $2.245 billion and adjusted EPS of $2.53 to $2.69
Second-quarter 2026 guidance: revenue of $540 to $556 million and adjusted EPS of $0.58 to $0.64
Share repurchase authorization raised to $500 million on May 8, 2026, including a planned $100 million accelerated share repurchase in the second quarter
SOLV Energy reported first-quarter 2026 revenue of $677 million, up 66% from a year earlier, and a net loss of $27 million, which included a one-time, non-cash expense of $52 million tied to modifying legacy equity awards from its IPO reorganization. The company raised its full-year 2026 Adjusted EBITDA guidance to $435 million to $455 million. For shareholders, operating growth was strong, but the reported loss widened and the company's chief strategy officer stepped down from that role.
Revenue was $677 million versus $408 million a year earlier; Adjusted EBITDA was $93 million, up 174% from $34 million.
Net loss was $27 million, including a one-time, non-cash expense of $52 million from modifying legacy equity awards; basic and diluted loss per share was $0.20 for February 12 to March 31, 2026.
Full-year 2026 guidance: revenue of $3.720 billion to $3.820 billion and Adjusted EBITDA of $435 million to $455 million.
Erik Johnson resigned as Chief Strategy Officer effective May 11, 2026, and will remain an employee through the end of 2026.
Qnity reported first-quarter 2026 net sales of $1.3 billion, up 18% from a year earlier, and raised its full-year 2026 guidance across all metrics. GAAP net income fell 19% to $162 million and GAAP diluted EPS fell 22% to $0.72, while adjusted EPS rose 33% to $1.08, a non-GAAP measure. Shareholders get higher sales and a raised outlook, but the GAAP profit decline is the key counterpoint.
Q1 2026 net sales $1,315 million, up 18% year over year; organic sales up 17%
GAAP net income $162 million, down 19%; GAAP diluted EPS $0.72, down 22%
Adjusted EPS $1.08, up 33%; adjusted operating EBITDA $411 million, up 22%
Full-year 2026 guidance: net sales $5.225 billion to $5.375 billion; adjusted EPS $3.80 to $4.14
Ovintiv reported a first-quarter 2026 net loss of $630 million, or $2.35 per diluted share, compared with a net loss of $159 million, or $0.61 per share, a year earlier. The loss was driven mainly by non-cash ceiling test impairments of $1.2 billion after tax, while total revenues rose to $2,532 million from $2,377 million. The company also declared a $0.30 per share quarterly dividend and reiterated its full-year 2026 production and capital guidance.
Q1 2026 net loss of $630 million ($2.35 per diluted share) vs. net loss of $159 million ($0.61 per share) in Q1 2025
Non-cash ceiling test impairments of $1.2 billion after tax, or $4.30 per diluted share, primarily due to a weaker SEC 12-month trailing oil price
Total revenues of $2,532 million vs. $2,377 million; Q1 cash from operating activities of $1.1 billion
Quarterly dividend of $0.30 per share payable June 30, 2026, to holders of record as of June 15, 2026
Life360 reported first-quarter 2026 revenue of $143.1 million, up 38% from a year earlier, and raised its full-year 2026 revenue and Adjusted EBITDA guidance. Net income fell to $2.8 million from $4.4 million, and the company posted an operating loss of $8.1 million, compared with operating income of $2.2 million a year earlier, as operating expenses rose 46%. Shareholders see faster top-line growth alongside lower profit and a higher cost base.
Q1 2026 revenue of $143.1 million, up 38% year over year; advertising revenue of $19.7 million, up 329%, after the Nativo acquisition.
Net income of $2.8 million, or $0.03 per diluted share, versus $4.4 million, or $0.05 per diluted share, a year earlier.
Full-year 2026 revenue guidance raised to $650 million to $685 million from $640 million to $680 million; Adjusted EBITDA guidance raised to $130 million to $140 million from $128 million to $138 million.
Gross margin fell to 77% from 81%, and operating expenses rose 46% to $118.6 million.
Hims & Hers reported first-quarter 2026 revenue of $608.1 million, up 4% from a year earlier, but swung to a net loss of $92.1 million from net income of $49.5 million in the same period of 2025. The company raised its full-year 2026 revenue guidance to $2.8 billion to $3.0 billion and set full-year Adjusted EBITDA guidance at $275 million to $350 million, which excludes the proposed Eucalyptus acquisition.
Q1 2026 Adjusted EBITDA was $44.3 million, down from $91.1 million, with margin at 7% versus 16%.
Gross margin fell to 65% from 73%, and United States revenue declined 8% to $529.9 million while Rest of the World revenue rose to $78.2 million.
Subscribers reached about 2.6 million at March 31, 2026, up 9% year over year.
Second-quarter 2026 guidance calls for revenue of $680 million to $700 million and Adjusted EBITDA of $35 million to $55 million.
Aura Biosciences reported first quarter 2026 results, with a net loss of $33.7 million, up from $27.5 million a year earlier. The loss per share narrowed to $0.50 from $0.55, and the company said a $280.8 million net-proceeds stock offering completed May 5, 2026, should fund operations into the second half of 2028.
Net loss was $33.7 million for the quarter ended March 31, 2026, versus $27.5 million a year earlier; basic and diluted loss per share was $0.50 versus $0.55.
Research and development expenses rose to $28.0 million from $23.3 million, mainly due to the Phase 3 CoMpass trial in early choroidal melanoma.
Cash, cash equivalents and marketable securities were $114.7 million at March 31, 2026, before the offering; about $39.0 million of offering proceeds was used to repurchase shares held by Matrix Capital Management Master Fund, LP.
Natalie Holles became Chief Executive Officer and President effective April 30, 2026, succeeding founder Elisabet de los Pinos, Ph.D.
Certara reported first-quarter 2026 revenue of $106.9 million, up 1% from a year earlier, but swung to a net loss of $8.8 million from net income of $4.7 million. The company also completed the $85.0 million cash sale of its medical writing business to Veristat on May 8, 2026, and updated its full-year 2026 revenue guidance to reflect the divestiture.
Revenue was $106.9 million, up 1% from $106.0 million; software rose 7% to $49.7 million and services fell 4% to $57.2 million.
Net loss was $8.8 million, or $0.06 per diluted share, versus net income of $4.7 million, or $0.03 per diluted share, in Q1 2025; adjusted EBITDA fell to $31.7 million from $34.8 million.
Sale of the medical writing business to Veristat closed May 8, 2026, for $85.0 million cash, plus $15.0 million in escrow and up to $35.0 million in earn-out payments.
Full-year 2026 revenue guidance is $395 million to $405 million, including about $18 million from the divested business; adjusted diluted EPS guidance is $0.35 to $0.41.
Kodiak reported first-quarter 2026 total revenue of $345.8 million, up from $329.6 million a year earlier, while net income attributable to common shareholders fell to $17.8 million, or $0.20 per diluted share, from $0.33 in the first quarter of 2025. The GAAP result included a $36.5 million loss on extinguishment of debt. The company raised full-year 2026 adjusted EBITDA guidance to $820 million to $860 million to include the Distributed Power Solutions (DPS) acquisition, which closed April 1, 2026.
Total revenues of $345.8 million versus $329.6 million in Q1 2025; Contract Services revenue was a record $307.0 million.
Adjusted net income of $52.0 million, or $0.59 per adjusted diluted share, versus $0.35 in Q1 2025; adjusted EBITDA of $190.1 million.
2026 adjusted EBITDA guidance raised to $820 million to $860 million, incorporating three quarters of DPS.
Total debt was $2.8 billion at March 31, 2026, and the quarter included a $36.5 million loss on extinguishment of debt.
HEI reported first-quarter 2026 net income of $30 million, or $0.18 per diluted share, up from $27 million, or $0.15, a year earlier. Excluding Maui wildfire-related costs and Pacific Current strategic review expenses, core net income fell to $31 million, or $0.18, from $40 million, or $0.23. The company also said leadership will be consolidated effective June 1, with Scott Seu becoming CEO of both HEI and Hawaiian Electric, and it expects higher utility operations and maintenance expenses for 2026.
GAAP net income was $30 million ($0.18 per diluted share) versus $27 million ($0.15) in Q1 2025; revenue was $746.4 million versus $744.1 million.
Core net income was $31 million ($0.18 per diluted share) versus $40 million ($0.23) in Q1 2025.
Hawaiian Electric expects 2026 O&M expense, excluding pension, to significantly outpace inflation, and the first of four $479 million settlement payments was issued in April.
Effective June 1, Scott Seu becomes CEO of HEI and Hawaiian Electric, and Shelee Kimura becomes President of both companies.
Dauch reported first quarter 2026 sales of $2.38 billion, up from $1.41 billion a year earlier, mainly because of the Dowlais acquisition. The company posted a net loss attributable to Dauch of $(100.3) million, or $(0.52) per share, compared with net income of $7.1 million a year earlier, while adjusted EBITDA rose to $308.5 million. It also raised its full-year 2026 sales range to $10.3 - $10.8 billion and its adjusted EBITDA range to $1.3 - $1.425 billion.
Q1 2026 sales were $2.38 billion versus $1.41 billion in Q1 2025.
Net loss attributable to Dauch was $(100.3) million, or $(0.52) per share, versus net income of $7.1 million, or $0.06 per share, a year earlier.
Adjusted EPS was $0.34 versus $0.22; adjusted EBITDA was $308.5 million versus $177.7 million.
Fluor reported first-quarter 2026 results on May 8, 2026. GAAP net earnings attributable to Fluor were $160 million, or $1.08 per share, compared with a loss of $241 million a year earlier, helped by a $124 million gain on the sale of CFHI. However, revenue fell 8% to $3.6 billion, adjusted EBITDA fell to $60 million from $155 million, and the company lowered the upper end of its 2026 adjusted EBITDA guidance, which matters to shareholders because it signals weaker expected profit for the year.
Revenue was $3.6 billion, down 8% year over year; GAAP EPS was $1.08 versus a loss of $1.42 a year earlier, while adjusted EPS was $0.14 versus $0.73.
Adjusted EBITDA guidance for 2026 was narrowed to $525 million to $560 million from $525 million to $585 million, citing cost growth on a mining project in the Americas and a temporary slowdown on another project due to Middle East geopolit
Mission Solutions posted a segment loss of $71 million, which included $96 million triggered by a court ruling on a lawsuit filed in 2013.
Q1 operating cash flow was $110 million, and share repurchases totaled $516 million, with the company targeting $1.4 billion for 2026.
Innospec reported first-quarter 2026 revenue of $453.2 million, up 3% from a year earlier, but GAAP diluted EPS fell to $1.22 from $1.31 and adjusted EPS fell to $1.05 from $1.42, with Performance Chemicals hit by a January 2026 US winter storm. The Board raised the semi-annual dividend 10% to $0.92 per share and authorized a new $75 million share repurchase program starting May 12, 2026.
Revenue $453.2 million vs. $440.8 million; Performance Chemicals operating income fell 46% to $10.7 million
GAAP diluted EPS $1.22 vs. $1.31; adjusted non-GAAP EPS $1.05 vs. $1.42
Semi-annual dividend of $0.92 per share, up 10%, payable May 29, 2026 to holders of record May 19, 2026
New $75 million buyback over three years replaces the $50 million authorization, of which about $16 million remained
Geospace Technologies reported fiscal second-quarter 2026 revenue of $19.7 million, up from $18.0 million a year earlier, but its net loss widened to $11.1 million, or $(0.86) per diluted share, from $9.8 million, or $(0.77). The company also said it will cut about 20% of its workforce, with expected annualized savings of roughly $12 million and about $1.3 million in restructuring charges.
Q2 revenue $19.7 million vs. $18.0 million a year earlier; Smart Water revenue fell to $3.7 million from $9.5 million
Six-month net loss $20.8 million, or $(1.62) per diluted share, vs. $1.4 million, or $(0.11), a year earlier; six-month revenue $45.3 million vs. $55.2 million
Workforce reduction of approximately 20% with a voluntary early retirement program; roughly $12 million annualized savings and about $1.3 million in restructuring charges expected in the second and third quarters of fiscal 2026
Cash and cash equivalents of $13.4 million at March 31, 2026, with $25.0 million of undrawn bank borrowing availability
Puma Biotechnology reported first quarter 2026 results, with total revenue of $44.8 million, down from $46.0 million a year earlier, and a GAAP net loss of $3.8 million, compared with net income of $3.0 million in the first quarter of 2025. The company raised its full-year 2026 total revenue and net income outlook, and said it repaid its remaining debt on May 4, 2026.
Total revenue was $44.8 million versus $46.0 million in Q1 2025; net product revenue was $42.0 million versus $43.1 million.
GAAP net loss of $3.8 million, or $0.07 per share, versus net income of $3.0 million, or $0.06 per share, a year earlier.
Full-year 2026 total revenue outlook raised to $222–$229 million from $214–$221 million; net income outlook raised to $16–$19 million from $10–$13 million.
Final payment under the 2021 Note Purchase Agreement was remitted on May 4, 2026, reducing outstanding debt to zero.
Block reported first-quarter 2026 gross profit of $2.91 billion, up 27% year over year, and Adjusted Diluted EPS of $0.85, up 52%, both above its guidance. It raised full-year 2026 guidance to $12.33 billion in gross profit and $3.85 in Adjusted Diluted EPS, but GAAP results included a $172 million operating loss and a $309 million net loss attributable to common stockholders, driven by $852 million in restructuring and other charges.
Q1 2026 gross profit was $2.91 billion, up 27% year over year; Cash App gross profit rose 38% and Square gross profit rose 9%.
GAAP diluted net loss per share was $0.52; Adjusted Diluted EPS was $0.85, a record.
Full-year 2026 guidance now calls for $12.33 billion in gross profit, $3.34 billion in Adjusted Operating Income and Adjusted Diluted EPS of $3.85.
Q1 charges included $852 million in restructuring and other charges tied to the February organizational change and accrued legal contingencies.
American Healthcare REIT (NYSE: AHR) reported first quarter 2026 GAAP net income attributable to controlling interest of $23.7 million, or $0.13 per diluted share, compared with a loss of $6.8 million a year earlier. It raised its full-year 2026 NFFO per diluted share guidance to $2.03 to $2.09, but lowered its full-year net income per diluted share guidance to $0.51 to $0.57 from $0.75 to $0.81.
Q1 2026 total revenues were $650.8 million, up from $540.6 million in Q1 2025; NFFO was $0.50 per diluted share, up from $0.38.
FY2026 NFFO per diluted share guidance rose to $2.03 to $2.09 from $1.99 to $2.05, and total portfolio Same-Store NOI growth guidance rose to 9.0% to 12.0% from 7.0% to 11.0%.
FY2026 net income per diluted share guidance fell to $0.51 to $0.57 from $0.75 to $0.81.
Net Debt-to-Annualized Adjusted EBITDA improved to 3.0x at March 31, 2026, from 3.4x at December 31, 2025.
Alarm.com reported first-quarter 2026 total revenue of $265.2 million, up 11.0% from a year earlier, and raised its full-year 2026 SaaS and license revenue guidance by $6.0 million at the midpoint. GAAP net income fell to $23.4 million from $27.7 million, and GAAP diluted EPS fell to $0.47 from $0.52, while non-GAAP adjusted EBITDA rose to $49.6 million. Cash and cash equivalents fell to $497.4 million after the company repaid $500.0 million of 0% convertible notes in January.
Total revenue rose 11.0% to $265.2 million; SaaS and license revenue rose 10.8% to $181.5 million.
GAAP net income was $23.4 million versus $27.7 million; GAAP diluted EPS was $0.47 versus $0.52.
Full-year 2026 SaaS and license revenue guidance is now $749.5 million to $750.5 million; non-GAAP adjusted EBITDA guidance is $215.0 million to $216.0 million.
Cash and cash equivalents were $497.4 million at March 31, 2026, down from $960.6 million at December 31, 2025, mainly due to the January 14, 2026 repayment of $500.0 million in convertible notes.
Akamai reported first quarter 2026 revenue of $1.074 billion, up 6% year over year, led by 40% growth in Cloud Infrastructure Services. Profit declined, with GAAP net income per diluted share at $0.71, down 13%, and non-GAAP net income per diluted share at $1.61, down 5%. The company also announced that a frontier model provider committed $1.8 billion over seven years for Cloud Infrastructure Services, and it issued second quarter and full-year 2026 guidance.
Q1 2026 revenue was $1.074 billion, up 6%; Security revenue was $590 million, up 11%
GAAP income from operations fell 26% to $114 million; non-GAAP income from operations fell 8% to $283 million
Q2 2026 revenue guidance is $1.075 billion to $1.100 billion; full-year 2026 revenue guidance is $4.445 billion to $4.550 billion
Non-GAAP EPS guidance is $1.45 to $1.65 for Q2 and $6.40 to $7.15 for full-year 2026
Motorola Solutions reported first-quarter 2026 sales of $2.7 billion, up 7%, and non-GAAP EPS of $3.37, up 6%, while GAAP EPS fell 14% to $2.18 amid a contingent Silvus earnout charge. The company raised its full-year 2026 revenue outlook to approximately $12.8 billion and its non-GAAP EPS outlook to $16.87 to $16.99, supported by record first-quarter backlog of $15.7 billion.
Q1 2026 sales of $2,714 million, up 7% from $2,528 million a year earlier; Software and Services sales up 18%
GAAP operating margin fell to 19.3% from 23.0%, mainly due to an increase in the contingent Silvus earnout
Full-year 2026 revenue outlook raised to approximately $12.8 billion from $12.7 billion; non-GAAP EPS outlook raised to $16.87 to $16.99 from $16.70 to $16.85
Operating cash flow was $451 million, down from $510 million a year earlier
Senseonics reported first quarter 2026 revenue of $11.7 million, up from $6.3 million a year earlier, and raised its full-year 2026 revenue outlook to $60 million to $64 million from $58 million to $62 million. The net loss widened to $32.3 million, or $0.71 per share, from $14.3 million, or $0.40 per share, as selling, general and administrative expenses rose after the company took over U.S. commercialization of Eversense.
Q1 2026 revenue was $11.7 million versus $6.3 million in Q1 2025; U.S. revenue was $9.3 million.
Full-year 2026 revenue outlook was raised to $60 million to $64 million, from $58 million to $62 million previously.
Selling, general and administrative expenses rose to $30.2 million from $7.7 million year over year.
Cash, cash equivalents and investments were $64.6 million, and outstanding indebtedness was $35.2 million, as of the quarter end.
Fox Factory reported first-quarter fiscal 2026 net sales of $368.7 million, up 3.9%, and a net loss of $15.0 million, versus a $259.7 million loss a year earlier that included a $262.1 million goodwill impairment. Adjusted EBITDA fell to $35.7 million from $39.6 million, and the company reaffirmed its full-year fiscal 2026 guidance. On May 6, 2026, it also amended its credit agreement, changing borrowing margins and the net leverage covenant.
Net sales were $368.7 million, up from $355.0 million; net loss was $15.0 million, or $0.36 per diluted share, versus a $259.7 million loss a year earlier.
Adjusted EBITDA was $35.7 million versus $39.6 million, and adjusted earnings per diluted share were $0.18 versus $0.23.
Second-quarter fiscal 2026 guidance: net sales of $343 million to $365 million and adjusted EBITDA of $32 million to $40 million; full-year guidance reaffirmed.
On May 6, 2026, the company signed a Sixth Amendment to its credit agreement with Wells Fargo Bank as administrative agent; the net leverage covenant is 5.00 through January 1, 2027, stepping down to 4.00 from June 30, 2028.
Covista reported third quarter fiscal 2026 results for the quarter ended March 31, 2026, with revenue of $487.0 million, up 4.5% year-over-year, and raised its fiscal 2026 revenue and adjusted earnings per share guidance. GAAP net income fell to $41.6 million from $60.8 million, and diluted EPS fell to $1.20 from $1.59, after a $16.3 million loss from discontinued operations. Shareholders get higher guidance and growing revenue, but reported profit declined in the quarter.
Revenue $487.0 million, up 4.5% year-over-year; up 8.4% when adjusted for a one-week Walden academic shift
GAAP net income $41.6 million vs. $60.8 million prior year; diluted EPS $1.20 vs. $1.59, including a $16.3 million loss from discontinued operations
Adjusted EPS $1.98 vs. $1.92 prior year
FY2026 revenue guidance raised to $1,930 million-$1,945 million from $1,900 million-$1,940 million; adjusted EPS guidance raised to $7.95-$8.15 from $7.80-$8.00
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.